Roche Offers $44B For South San Francisco Giant Genentech

Roche (ADR: RHHBY) has offered $44B for Genentech (NYSE: DNA). The two companies both have a presence in the Bay Area, with Roche having offices in Palo Alto, and Genentech being headquartered in South San Francisco.

Genentech currently occupies 48 buildings in South San Francisco. 13 of those are owned with the balance being leased.

If this transaction is successful (which it is likely to be given that Roche already owns a significant portion of Genentech), then this would represent the second time Roche has owned Genentech.

Similar Posts:

• Broadway Partners Runs Into Trouble - San Francisco Holdings On The Table?
• Facebook Moving to Stanford Research Park Office Space
• Brocade to Buy Foundry Networks; Combine for a 800K SF Silicon Valley Footprint
• Amgen Shedding 365,000 SF of Space in South San Francisco
• Hewlett Packard Reducing Real Estate Footprint by 25% in Cupertino and Palo Alto

Leave a comment